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ABSTRACT
Background: In spite of many advances in the management of diabetes in the last 25 
years, the mortality associated with diabetic ketoacidosis (DKA) remains high, especially 
in the developing countries. The mortality appears greatest in the first 24 - 48 hours 
of their treatment. Most of the previous studies on DKA focused on children and the 
precipitating factors thereof but not particularly on clinical predictors of outcomes.
Objective: To determine the clinico-laboratory predictors of outcomes of patients 
hospitalised with diabetic ketoacidosis who were undergoing treatment.
Design: Cross-sectional descriptive study.
Setting: The accident and emergency department and medical wards of the Kenyatta 
National Hospital.
Subjects: Fifty one patients hospitalised with diabetic ketoacidosis over a nine month 
period were evaluated clinically and by laboratory tests. They were managed in the 
standard way with insulin, intravenous fluids and appropriate supportive care. 
Main outcome measures: Serial assays of serum electrolytes, glucose and blood pH, 
HbA1c and clinical outcome of either discharge home or death.
Results: Of  the 51 patients enrolled, 47 were included in the final analysis. Fourteen 
(29.8%) patients died, and the deaths occurred within less than 48 hours of hospitalisation 
and treatment. Of the patients who died, all (100%) had altered level of consciousness at 
hospitalisation, 71.4% had abnormal renal functions, 64.3% were newly diagnosed and an 
equal proportion of 64.3% were females. The alteration in the level of consciousness was 
significantly associated systolic hypotension and severe metabolic acidosis, (p<0.001). 
Patients with altered level of consciousness also had poorer renal function.
Conclusion: Apparently DKA still carries high mortality during treatment in hospital. 
Altered level of consciousness, which is an obvious and easily discernible clinical 
sign, was a major predictor of mortality in our study patients. The majority of patients 
with altered level of consciousness also had systolic hypotension, severe metabolic 
acidosis and impaired renal function. Even where and when detailed laboratory 
evaluation is elusive, clinical signs, especially altered level of consciousness and systolic 
hypotension are very important markers of severity of DKA that may be associated 
with unfavourable outcomes. Further studies are necessary to establish why DKA still 
carries high mortality in the patients who are already receiving treatment in hospitals 
in developing countries.
INTRODUCTION
Despite advances in diabetes management over the 
past 25 years, the incidence of mortality associated 
with diabetes ketoacidosis (DKA) remains unchanged 
(1).  The mortality appears to be greatest among 
patients at first presentation (2), if there has been a 
long history of symptoms before hospitalisation (3) 
and during the first 24 hours of treatment (4).  Most 
of these studies have been on children.
  In developing countries, mortality from diabetes 
ketoacidosis has been unfavourably high. McLarty 
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et al (5) found that patients requiring insulin pre-
hospitalisation had particularly worse hospital 
survival than those that did not require insulin, 
amongst the former 26% died of DKA.  Ahmed et 
al (6) found that DKA was responsible for 54% of 
diabetic hospitalisations in a Sudanese hospital over 
a two year period.  This Sudanese study did not 
specify important clinico-laboratory predictors of 
outcomes.
  We picked in this study, some easily measurable 
clinico-laboratory parameters and evaluated their 
relationship with the outcome of our patients who 
were hospitalised with diabetic ketoacidosis.
MATERIALS AND METHODS
This was a prospective descriptive study carried out at 
the Kenyatta National Referral and Teaching Hospital 
from December 2001 to August 2002.  The study was 
approved by the institutional review board.  The 
main objective was to evaluate clinical and laboratory 
characteristic and outcome of diabetic patients who 
were hospitalised in diabetes ketoacidosis state 
within the study period.  The main outcomes were 
either death or successful discharge from the hospital. 
Apparently, most of the patients succumbed within 
the first 30-48 hours of hospitalisation. Diabetes 
ketoacidosis was defined as hyperglycaemia above 
14.0 mmol/l, an arterial blood pH less than 7.3, serum 
bicarbonate less than 15 mmol/l with moderate to 
marked ketonuria, qualitatively assessed as ketonuria 
(2+ to 3+) (7).  Patients were consecutively recruited 
and enrolled into the study if on satisfying the study 
definitions and consent obtained either from self or 
guardian.  This was a clinical study of usual care and 
there were no other unusual study requirements. 
There was a likely benefit of closer supervision of 
treatment and frequent laboratory monitoring.
  Within the study period of nine months, 648 
patients with diabetes were hospitalised through the 
accident and emergency unit to the various wards 
– medical, surgical or intensive care units of the 
hospital.  The clinical state of the patient determined 
which ward was appropriate for stay of the study 
patient, with assistance of one of the authors (PKM). 
Fifty one (51/648), about 8% of the patients met the 
inclusion criteria, consent was obtained and were 
consequently enrolled into the study.  The patients 
presented to the hospital at any time of the 24 hour 
day, and the initial evaluation was done at the accident 
and emergency department.
  For each patient, a medical history was taken, 
where possible, to include time of onset and duration 
of symptoms, the age, diabetes history and mode 
of glycaemic control.  Physical examination was 
extensively performed; vital signs of temperature, 
respiratory rate, pulse and blood pressure on the arm 
from a lying position were determined and recorded. 
Important parameters in the physical examination 
were level of hydration, identification of acidotic 
(Kussmaul) breathing (8), and level of consciousness 
based on Glasgow Coma Scale (GCS) (9).  During 
the systemic physical examination, clinical evidence 
of any other disease process like meningitis, chest 
infection, etc, were looked for.
  The first elaborate laboratory assays were taken 
at the initial evaluation, within or less than two 
hours of presenting to hospital.  The time lapse was 
related to registration procedures of a patient going 
on the ward. However, any patient who required any 
resuscitation was addressed appropriately without 
undue delay.  The first laboratory assays were random 
blood glucose (by hand glucometer) and dipstick 
ketonuria for diagnosis.  Other laboratory tests were: 
total blood gas and pH analysis, serum magnesium, 
phosphates, liver function profile and blood cultures 
where indicated. These tests were taken on the first 
intravenous canulation before intravenous fluids 
were commenced. The next blood samples were 
taken within six hours of a patient’s hospitalisation 
or from the time initial samples were taken; 24 hours 
and then daily for arterial blood pH and gases and 
renal functions (especially creatinine and electrolytes-
Na and K).  Blood glucose levels were determined 
two hourly until the DKA state was fully reversed 
clinically.  Any other necessary blood tests that were 
done within less than six hours of hospitalisation 
were not used in the data analysis.
  The treatment that was given to each study 
patient consisted of soluble insulin, intravenous fluids 
of either normal saline or dextrose or Hartmanns 
solutions and any other necessary requirement as 
appropriate for the individual patient. 
  Other investigations were done on patients 
as indicated/necessary including plane chest 
radiograph; urinalysis including microscopy and 
culture/sensitivity; and electrocardiogram.
  Specific laboratory methods were: random blood 
glucose was done by “Surestep” glucometer (Lifescan, 
Johnson & Johnson, USA), which detects maximum 
blood glucose of 27.8 mmol/l, also gives blood glucose 
results 10-15% less than plasma glucose.
  Arterial blood was obtained from brachial or 
radial artery for pH gas analysis on an automated 
machine (rapid Lab 348, Bayer Diagnostics, Colchester 
Rd, Halstead, England).  Urine was obtained as 
mid-stream specimen in the conscious or by aseptic 
catheterisation in the comatose patients on which 
culture and sensitivity was done in appropriate 
media.
  Total blood count was done on 2ml EDTA 
blood in automated machine (Cell Dyn 1300 Abbot 
Laboratories, USA).  Urea and electrolytes (Na+, K+, Cl- 
including Mg+, phosphates) in 3 ml serum specimen 
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were done in automated machine (Technicon R.A. 
1000 analyzer), using IMx analyzer machine (Abbot 
Laboratories, USA).
Data analysis and statistical methods: SPSS 10 package 
was used.  Data were summarised in proportions 
for categorical ones, and into means (S.E.) or SD 
for the continuous variables.  Specific continuous 
variables like blood pH and serum creatinine were 
categorised as either normal or abnormal and the 
patients in either category reported as proportions. 
Comparison of means (S.D) were done using student 
t-tests, associations were tested using Fisher’s Chi-
square test. 
RESULTS
Fifty one of 648 patients hospitalised with diabetes 
within a nine-month period had diabetic ketoacidosis, 
and were enrolled into the study.  Out of the 51 
patients, one died before the full investigations were 
done, another three were excluded for incomplete 
data. Finally 47 study participants were analysed 
and 46.8% were female.
Table 1
Socio-demographic profile of patients with diabetic ketoacidosis in the study
Characteristic  Total population   Males   Females  
 No.  (%) No. (%) No. (%)
Number (%)  47   100  25  53.2  22  46.8 
Mean age (years) ± (SD)  33.42 ± 15.21 37 ± 18.12  29.86 ± 14.3 
Newly diagnosed diabetics  24   51.1  14  58.3 10  41.7 
Previously known diabetics  23   48.9  11  47.8  12  52.2 
Mean duration of diabetes (years)  4.64 ± 5.62  5.0 ± 4.42  3.40 ± 3.70 
Patients with HbAIc ≤ 7.0%  1   2.1  1   0.5  0   0 
                      (>7 - 8%)  2   4.3  1   50  1   50 
                      (> 80%)  44  93.6  20  45.5  24  54.5 
Figure 1
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Figure 2
Prevalence of selected symptoms of study patients at initial presentation to hospital
Figure 2 above emphasizes the two major symptoms 
of polyuria (85.1%) and vomiting (42.5%) that 
were responsible for enhancing water loss on the 
background of inadequate oral intake.
Table 2
Clinical signs of the study patients at initial hospitalisation
Level of consciousness                            Proportion of patients 
 No.  (%)
GCS 13-15 – fully conscious  19   40.4
GCS 9-12 – drowsy 11   23.4
GCS 3-8 – obtunded to coma 17   36.2
Hydration status 
  Mild dehydration 12   25.5
  Moderate dehydration 20   42.6
  Severe dehydration 15   31.9
Vital signs 
  Tachycardia (>100 beat per minute) 14   29.8
  Hypotension (SBP <100mHg) 17   36.2
  Hypothermia (T<350) 18   37
  Acidotic (Kussmaul) breathing  36   76.6







% of patients 






70 EAST AFRICAN MEDICAL JOURNAL February 2010 
Table 3
Characteristics and laboratory parameters of the study patients by their first renal function status at hospitalisation
 
 First serum creatinine level at hospitalisation
Parameter Normal serum  Abnormal serum 
 Creatinine ≤ 120 µmol/l Creatinine >120 µmol/l
Proportions n = 18 n = 29
No. of patients who died 5/18 (27.8) 9/29  (31.0)
Age (years) (mean + SD) 30.28 (16.82) 35.76  (16.50)
HbAlc (%) (mean + SD) 13.32 (1.84) 12.40  (2.08)
Duration of diabetes (years) (mean + SD) 0.92  (1.26) 3.11   (5.6)
pH at 6 hours of hospitalisation (mean + SD) 7.25  (0.17) 7.26   (0.12)
pH at 24 hours of hospitalisation (mean + SD) 7.32  (0.13) 7.34   (0.03)
Random blood glucose at hospitalisation 
(mmol/l)(mean + SD) 26.9  (2.4) 26.9   (2.6)
Potassium (K+) at hospitalisation(mmol/l) (mean + SD 5.80  (1.4) 5.6    (1.6)
Potassium (K+)(mmol/l) (mean + SD) at 24 hours 3.9   (0.6) 4.1    (0.9)
Systolic BP at hospitalisation (mmHg) (mean + SD) 105.6 (13.8) 113.1  (17.3)
Diastolic BP at hospitalisation (mmHg) (mean + SD) 61.7  (11.5) 65.4   (11.4)
BUN mmol/l (mean + SD) 6.9   (5.1) 15.5   (9.8)**
**P<0.01, significant difference
BP=Blood Pressure
BUN=Blood Urea Nitrogen 
Table 4
Characteristics and laboratory parameters of the study patients by their level of consciousness at hospitalisation
 Normal level of  Abnormal level of
 consciousness  consciousness
Proportion of patients 19/47 28/47
Proportion of patients who died 0/19 14/28**
Age (years) (mean + SD) 33.4   (19.0) 33.7  (16.3)
HbAlc (%) (mean + SD) 13.12  (1.11) 12.6  (2.17)
pH at 6 hours of hospitalisation (mean + SD) 7.31   (0.08) 7.24  (0.15)
pH at 24 hours of hospitalisation (mean + SD) 7.36   (0.06) 7.32  (0.01)
First random blood glucose (mmol/l) (mean + SD) 26.9   (2.6) 26.9  (2.5)
First potassium (K+) at hospitalisation (mean + SD) 4.2    (0.7) 4.9   (0.45)
Potassium (K+) at 24 hours hospitalisation (mean + SD) 4.0    (0.34) 4.10  (0.9)
Systolic BP (mmHg) at hospitalisation (mean + SD) 113.3  (14.1) 109.5 (16.9)+
Diastolic BP (mmHg) at hospitalisation(mean + SD) 64.4   (5.3) 63.8  (12.6)
Duration of diabetes (years) (mean +SD)  0.81   (1.30) 2.62  (4.96)
BUN mmol/l (mean + SD) 7.26   (4.42) 13.4  (9.76)*
** Chi-square, p<0.01, abnormal level of consciousness was significantly associated with death
* Student t-test, p<0.05, patients with abnormal level of consciousness had poorer renal function
+ Systolic hypotension was significantly (p = 0.009) associated with severe acidosis
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Table 5
Summary of clinical characteristics/events of the study patients who died 
Clinical/laboratory characteristic  Proportion of patients with 
 the characteristic who died (%)
Abnormal renal function 71.4
Altered level of consciousness 100
Newly diagnosed patients with diabetes 64.3
Females 64.3
 
Fourteen of 47 (29.8%) of the patients who died were 
analysed, 71.4% had abnormal renal function profiles, 
all (100%) had altered level of consciousness, 9/14 
(64.3%) were newly diagnosed and 9/14 (64.3%) 
were females.
Renal dysfunction at hospitalisation (first serum 
creatinine level > 120 µmol/l) was significantly 
associated with altered level of consciousness 
(p=0.010), however, altered level of consciousness 
per se was more significantly (p=0.028) associated 
with death than renal dysfunction.
DISCUSSION
Table 1 and Figure 1 show the characteristics of the 
study participants.  Twenty four (51.06%) patients 
were <30 years of age, who were likely to have 
type 1 diabetes. The other category of study subjects 
above 30 years, probably a mixture of type 1 and 2 
but more of type 2 diabetes, had more men. There 
was possibility that the more male numbers found 
could be a chance finding due to bias from patient 
preference in accessing the hospital facility or it may 
have been a real observation.
  Other authors, (10-12) have shown a 2-3 fold 
higher prevalence of ketosis-prone type 2 diabetes 
in men. These studies did not compare mortality 
between men and women.
  Diabetic ketoacidosis (DKA) appears to be a 
major cause of mortality in diabetic patients who are 
hospitalised. This study recorded a mortality of 29.8%. 
The glycaemic level was very high thus betraying 
the underlying insulin deficiency at hospitalisation. 
McLarty et al (5) found that patients that required 
insulin had particularly worse hospital survival (26% 
died of DKA) than those that did not require insulin. 
Ahmed et al (6) also found lack of insulin as the main 
precipitant of DKA.
  Often when death occurs in DKA, it is 
listed as a clinical entity, occasionally additional 
complications may be included like cerebral 
or pulmonary oedema but scarcely are these 
accompanying clinical events/processes like renal 
dysfunction, cerebral oedema and/or hypotension 
mentioned on death certificates (13).
  In this study, the first assay of renal profile at 
hospitalisation, categorised as abnormally raised 
serum creatinine (>120mmol/l) was detected in 
about 62% of the study patients, (Table 3).  Over 70% 
of patients who died had abnormal renal function 
(Table 5).  Some published reports (14, 15) have 
described non-diabetic glomerular disease occurring 
in patients with diabetes mellitus, particularly with 
early onset proteinuria.  Our study did not look for 
proteinuria.  Moreover, in DKA, other potential risk 
factors/causes of renal dysfunction may occur, and 
these include diabetes itself, dehydration, infection 
and undetermined glomerular disease.  More than 
70% of our study patients had moderate to severe 
dehydration, (Table 2), with symptoms of vomiting, 
polyuria and hyperventilation (Figure 2), all these 
possibly caused and/or worsened the state of 
dehydration, especially on a backdrop of inadequate 
oral intake.  Harrington et al (15) reported renal failure 
as an initial manifestation of diabetes, however, their 
patients did not have DKA. Pre-renal causes of kidney 
dysfunction may play a major role in diabetic patients 
in ketotic state such as our subjects were in. 
  All patients in our study who died had altered 
level of consciousness and poorer renal functions 
compared to those ones without alteration in the 
level of consciousness, (Table 4). This means that 
alteration in the level of consciousness was a more 
frequent association with mortality followed by renal 
dysfunction.  The altered level of consciousness in 
this study was noted to be a sign of severe acidosis 
(low pH). The study patients whose serum pH 
values were low were also observed to have systolic 
hypotension. 
  Altered level of consciousness may be due to 
metabolic derangements inherent in (characteristic of) 
DKA as well as therapeutic interventions especially 
of fluid therapy.  That many of our patients presented 
with altered level of consciousness before therapy 
was initiated vindicate the probable role of abnormal 
energy metabolism and metabolic derangements 
in diabetic ketoacidosis that results in abnormal 
biochemistry which also affects central neurological 
function (2).  The idea that the treatment of DKA itself 
might be the cause of cerebral oedema has gained 
72 EAST AFRICAN MEDICAL JOURNAL February 2010 
support over the years, but no single aspect of therapy 
has been implicated in studies to date, furthermore 
cerebral eodema has been shown to be present even 
before treatment begins (17, 18).
  Most (>80%) of all our study patients had 
clouding of consciousness but other studies (19-21) 
have reported a modest (less than 20%) proportion 
presenting with altered level of consciousness.  The 
disparity in proportions of patients with altered level 
of consciousness in the different studies may be a 
reflection of time taken before the patients presented 
to hospital from onset of diabetic ketoacidosis, and 
probably the severity of disease at hospitalisation.
  It is therefore evident that dehydration, 
hypotension, altered level of consciousness and renal 
dysfunction were major risk factors of unfavourable 
outcome (mortality) in DKA in our study patients. 
These have major implications on management of 
DKA, especially fluid and insulin therapies that 
are very central to reversing the effects of diabetic 
ketoacidosis.
  Acute dehydration with a relatively larger 
sodium loss will result primarily in intravascular 
dehydration, but a more prolonged process will 
result in greater degree of intracellular dehydration, 
with relative maintenance of intravascular volume, 
particularly if the patient remains polydypsic (22).
  In this study, the newly diagnosed patients also 
had very high HbAlc values that reflected several 
weeks of hyperglycaemia, or presumably long period 
of evolution of the DKA state.  There are therefore 
wide variations in fluid deficits, and acid-base and 
electrolyte imbalances, during both development and 
treatment of diabetic ketoacidosis (23), yet only few 
of these differences in diabetic ketoacidosis have been 
well documented (24).  In deed this protean clinical 
picture may receive several interpretations from 
clinicians, which consequently would translate into 
varied therapeutic emphasis in the course of treating 
DKA.  
  Of particular concern is the evidence that clinicians 
tend to overestimate the degree of dehydration in 
diabetic ketoacidosis (25, 26).  It is accepted that safe 
therapy of hypertonic dehydration requires both 
prolonged and cautious approach to fluid replacement 
to avoid the development of fits and cerebral oedema 
during the rehydration therapy (27).
  Halting the metabolic decompensation process 
in DKA using insulin is the initial therapeutic goal. 
The other goal is provision of sufficient fluid to 
restore renal and hormonal homeostasis over a 
period of time that may be comparable to that taken 
for the problem to develop. In our study, it was 
evident that treatment had the effect of lowering 
potassium, this was observed in the first 24 hours, 
(Table 3). Most guidelines are clear on how potassium 
replacement should be effected in DKA to avoid any 
catastrophes.
  The differences in the biochemical and clinical 
pictures of patients with DKA occasioned by 
variations in the duration from onset, degrees of 
insulin deficiency and precipitating factors attests 
to the magnitude of challenges in their successful 
management.  It is no wonder that when these 
challenges in resource-poor settings are inadequately 
met, mortality remains high.  From this study, patients 
coming to hospital in diabetic ketoacidosis who were 
likely to die were (had); the newly diagnosed, female 
gender, younger age of less than thirty, presence of 
renal dysfunction and, most significantly, altered 
level of consciousness. 
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